Announcements Trials
Browse Landscape

Status

Enrolling by invitation 1

Sponsor Class

OTHER_GOV 1OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Other 1

Conditions

Obesity 14Polycystic Ovary Syndrome 6Sexual Dysfunction, Physiological 3Mucositis 3Endometrial Neoplasms 3Rectal Neoplasms 2Overweight 2Obesity, Morbid 2Neoplasms 2Insulin Resistance 2Head and Neck Neoplasms 2Dyspnea 2Chemotherapy-induced Peripheral Neuropathy 2Breast Neoplasms 2Vitamin D Deficiency 1Urinary Incontinence 1Transfusion-Related Acute Lung Injury 1Stomach Neoplasms 1Spondylitis, Ankylosing 1Smoking 1Radiation Induced Oral Mucositis 1Pulmonary Edema 1Pulmonary Disease, Chronic Obstructive 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Opioid-Induced Constipation 1Nutrition Disorders 1Noncommunicable Diseases 1Lymphoma, Follicular 1Intestinal Diseases 1Infertility 1

Interventions

Electrocardiography 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER_GOV × Noncommunicable Diseases × Other × Clear all
NCT06812767 2025-02-06

FORTUNE

National Medical Research Center for Therapy and Preventive Medicine

Enrolling by invitation
2,000 enrolled
Other

Noncommunicable Diseases, Alcohol Drinking, Asthma, Cerebrovascular Disorders, Coronary Disease, Diabetes Mellitus, Hyperglycemia, Hypertension, Neoplasms, Obesity, Smoking, Hypokinesia, Pulmonary Disease, Chronic Obstructive, Dyslipidemias, Overweight

Data powered by HemOnc (CC BY 4.0) Colophon âš¡